(IN BRIEF) AstraZeneca and Quell Therapeutics have announced a collaboration to develop innovative treatments for Type 1 Diabetes and Inflammatory…
(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity…
(IN BRIEF) Sanofi has agreed to acquire Provention Bio, a U.S.-based biopharmaceutical company focused on preventing and intercepting immune-mediated diseases,…
4 million1 hours of hypoglycemia avoided Trust in the algorithm leads to fewer meal declarations Users report a significantly reduced…
High-growth diabetes company Diabeloop closes its Series C financing round - led by LBO France, joined by Terumo Corporation, Innovacom…
(PRESS RELEASE) PARIS, 28-Apr-2022 — /EuropaWire/ — ATTD 2022 - Diabeloop, pioneer in therapeutic artificial intelligence for diabetes management, presents…
(PRESS RELEASE) PARIS, 12-Apr-2022 — /EuropaWire/ — Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential…
EASD 2021 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data(1) of its…
BIRMINGHAM, 22-4-2015 — /EuropaWire/ — Researchers from the University of Birmingham have identified an important new way in which our…